Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Synergistic treatment of solid tumours by engineering novel synthetic communication systems in T cells and Macrophages

Project description

Engineered immune cells against solid tumours

Cancer immunotherapy has significantly advanced treatment options for many patients. However, solid tumours remain largely resistant. One major challenge is the tumour microenvironment, which inhibits immune cell function and limits the effectiveness of existing cell-based therapies. Enhancing coordination among different immune cell populations to detect and counteract these suppressive mechanisms may improve therapeutic outcomes. The ERC-funded TeaM project aims to combine synthetic biology, immunology and machine learning to engineer communication systems between T cells and macrophages. These synthetic circuits will detect immunosuppressive signals within tumours and trigger precise, localised therapeutic responses. The proposed multicellular approach is aimed at being able to reprogramme the tumour microenvironment and restore anti-cancer immune activity.

Objective

In TeaM I propose a synthetic biology-based multi-cellular strategy to fight solid tumors, addressing the immunosuppressive tumour microenvironment (TME).
WHY: Synthetic biology is transforming cell-based immunotherapies with control circuits in immune cells like T cells and macrophages. However, in solid tumours the TME renders these cells dysfunctional, limiting their efficacy. Innovative solutions are needed to address this unmet need and unlock the full potential of immunotherapies.
WHAT: TeaM integrates synthetic biology, immunology, and artificial intelligence to arm CD8+T cells and macrophages with synthetic communication systems that sense the immunosuppressive TME and activate precise and localized therapeutic response.
HOW: In the past years, also supported by an ERC Starting grant I made key contributions to mammalian cell engineering, addressing important bottlenecks with innovative solutions. Motivated by this progress, I am ready to challenge my know-how and investigate new frontiers in cell-based immunotherapies, driving revolutionary possibilities for cancer treatment.
Leveraging my expertise in mammalian synthetic biology, we will design circuits that decode and reprogram the TME.
Key innovations include: 1) Synthetic receptors targeting TME-specific molecules; (2) Humanized transcriptional activators; (3) Cell type-specific synthetic promoters devoid of off-target effects; (4) A Machine Learning model to optimize codon usage for balanced gene expression. These innovations will improve immune cell engineering for therapeutic interventions.
IMPACT: TeaM will enable non-invasive real time characterization of TME dynamics under different therapeutic pressures improving our understanding of tumour responses, in preclinical studies. Moreover, it will be a breakthrough in cell therapies by coordinating therapeutic genes expression for TME reprograming and anti-cancer activity of engineered T cells and macrophages.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 2 437 500,00
Address
VIA MOREGO 30
16163 Genova
Italy

See on map

Region
Nord-Ovest Liguria Genova
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 2 437 500,00

Beneficiaries (1)

My booklet 0 0